Episode Synopsis "Episode 181: ACT Outpatient and Inpatient Trials"

Sanjit Jolly and C. Michael Gibson discuss if colchicine and rivaroxaban plus aspirin can slow disease progression in patients hospitalized with COVID-19.

Listen "Episode 181: ACT Outpatient and Inpatient Trials"

More episodes of the podcast Talking Points

• The AXIOMATIC - SSP Trial
• The EBRAVE - AF Trial
• The INVICTUS Trial
• The FRAME-AMI Trial
• MASTER DAPT: Long-Term Results
• Episode 180: The PANTHER Trial
• Radial vs. Femoral Access for PCI: Meta-Analysis
• Episode 181: ACT Outpatient and Inpatient Trials
• Episode 180: The VALOR-HCM Trial
• Episode 179: The SODIUM-HF Study
• Episode 178: The COMPLETE Trial
• Episode 177: The EDIT-CMD Trial
• Episode 176: The IVVE Trial
• Episode 175: The METEORIC-HF Trial
• Episode 174: The DIAMOND Trial
• Episode 173: MAVA-LTE: The EXPLORER-LTE Cohort